|
시장보고서
상품코드
2088963
의료 예측 분석 시장 : 컴포넌트별, 데이터 유형별, 기술별, 전개별, 조직 규모별, 용도별, 최종 사용자별 시장 예측(2026-2032년)Healthcare Predictive Analytics Market by Component, Data Type, Technology, Deployment, Organization Size, Application, End User - Global Forecast 2026-2032 |
||||||
360iResearch
의료 예측 분석 시장은 2032년까지 연평균 복합 성장률(CAGR) 18.79%로 성장이 전망되며, 611억 7,000만 달러 규모로 확대될 것으로 예측됩니다.
| 주요 시장 통계 | |
|---|---|
| 기준 연도 : 2025년 | 183억 2,000만 달러 |
| 추정 연도 : 2026년 | 216억 달러 |
| 예측 연도 : 2032년 | 611억 7,000만 달러 |
| CAGR(%) | 18.79% |
의료 예측 분석은 사후 보고에서 의료 제공, 지역 주민의 건강, 보험사 업무, 생명과학 등 각 분야에 걸친 증거 기반의 실시간 의사결정 지원으로 전환되고 있습니다. 이 분야에서는 임상 데이터, 보험 청구 데이터, 의료기기 데이터, 조제 데이터, 검사 데이터, 영상 진단 데이터, 사회적 결정 요인 및 업무 데이터를 활용하여 위험 예측, 수요 예측, 품질 향상 및 회피 가능한 비용 절감을 도모하고 있습니다.
이 시장은 측정 가능한 의료 시스템에 대한 요구에 의해 형성되고 있습니다. 세계보건기구(WHO) 보고서에 따르면, 비전염성 질환이 전 세계 사망 원인의 약 74%를 차지하고 있으며, 한편 유엔은 65세 이상 인구의 비율이 2022년 10%에서 2050년까지 16%로 상승할 것으로 예측했습니다. 이러한 인구 통계 및 만성 질환 동향으로 인해 재입원 위험 예측, 질병 진행 모델링, 인력 배치 최적화, 부정 행위 감지, 복약 순응도, 가치 기반 의료 성과 관리 등 의료 예측 분석에 대한 지속적인 수요가 발생하고 있습니다.
의료 분석 분야의 혁신적인 변화
의료 예측 분석의 현황은 상호 운용 가능한 데이터 생태계, 클라우드 기반 분석, 가치 기반 보상 제도, 원격 환자 모니터링, 그리고 규제 현대화를 통해 혁신이 진행되고 있습니다. HL7 FHIR 등의 표준 규격으로 인해 전자건강기록(EHR) 데이터의 활용성이 향상되는 한편, 연결 기기 및 가상 진료 플랫폼의 보급으로 예측 모델링에 활용할 수 있는 종단적 건강 데이터의 양이 증가하고 있습니다.
인공지능(AI)의 누적 영향
인공지능은 패턴 인식, 자연어 처리, 이미지 분석, 치료 격차 파악 및 다중 모드 위험 점수 산정을 개선함으로써 의료 예측 분석의 영향을 더욱 증폭시키고 있습니다. 미국 식품의약국(FDA)은 AI가 탑재된 의료기기를 수백 건 승인했으며, 특히 방사선과, 순환기내과, 신경과가 가장 활발한 분야로 꼽히고 있습니다. 이는 AI를 활용한 의사결정 도구의 임상 현장 도입이 가속화되고 있음을 보여줍니다.
주요 지역별 인사이트
북미는 전자의무기록 도입이 성숙 단계에 이르렀고, 보험사 대상 분석이 고도로 발달했으며, 견고한 클라우드 인프라가 구축되어 있고, 가치 기반 의료에 대한 지속적인 투자가 이루어지고 있어 의료 예측 분석의 주요 지역으로 자리매김하고 있습니다. 특히 미국의 경우, CMS 데이터에 따르면 국민 의료비가 GDP에서 차지하는 비중이 높기 때문에 이용 관리, 재입원 감소, 품질 향상 및 부정 방지 목적으로 예측 모델을 활용해야 한다는 압박이 커지고 있습니다. 캐나다에서는 각 주의 디지털 헬스 시스템, 인구 건강 이니셔티브, 그리고 공공 부문의 건강 형평성에 대한 집중적인 노력을 통해 지역의 성숙도가 더욱 높아지고 있습니다.
주요 지역별 인사이트
아세안(ASEAN) 국가들의 경우, 회원국들이 보편적 의료 보장, 디지털 신원 확인, 원격 의료, 병원 현대화를 확대하고 있어 장기적인 잠재력이 매우 높다고 할 수 있습니다. 예측 분석의 도입 현황은 지역 내에서도 편차가 있지만, 싱가포르, 말레이시아, 태국, 인도네시아, 베트남, 필리핀과 같은 고성장 시장에서는 집단건강관리, 감염병 감시, 보험 청구 분석, 만성 질환 관리 최적화에 대한 수요가 증가하고 있습니다.
주요 국가에 대한 인사이트
미국은 전자의무기록의 광범위한 도입과 성숙한 보험 청구 데이터를 바탕으로, 보험사 및 의료 제공업체 대상 분석, AI를 활용한 임상 의사결정 지원, 그리고 가치 기반 의료의 활용 사례에서 선도적인 위치를 차지하고 있습니다. 캐나다는 주 차원의 데이터 시스템, 건강 형평성, 가상 진료 통합, 그리고 공공 부문의 디지털 헬스 현대화에 중점을 두고 있습니다. 멕시코와 브라질은 의료 접근성, 보험 청구 적정성, 병원 효율성, 공중보건에 관한 분석을 확대하고 있으며, 특히 브라질의 대규모 통합 의료 시스템은 집단건강관리 분야에서 큰 잠재력을 지니고 있습니다.
업계 리더를 위한 실용적인 제안
업계 리더는 임상적, 재무적 또는 운영상의 책임이 명확한 고부가가치 예측 분석 활용 사례를 우선시해야 합니다. 단기적으로 가장 유망한 기회로는 재입원 방지, 응급실 수요 예측, 패혈증 및 상태 악화 경보, 복약 순응도, 위험 조정, 사전 승인 최적화, 부정·낭비·남용 감지, 인력 배치 계획 등이 있습니다.
조사 방법론
본 요약 보고서는 검증된 공개 정보원, 규제 지침, 의료 시스템 데이터 세트, 그리고 의료 예측 분석과 관련된 업계 증거에 대한 체계적인 검토를 바탕으로 작성되었습니다. 주요 정보원으로는 세계보건기구(WHO), 유엔, OECD, 각국 보건 기관, CMS, FDA, 유럽 집행위원회, 세계은행의 데이터 및 간행물, 그리고 동료 심사를 거친 의료정보학 연구가 포함됩니다.
결론
의료 예측 분석은 비용, 인력 제약, 수요 증가를 관리하면서 성과 향상을 목표로 하는 의료 시스템, 보험사, 정부 및 생명과학 기업에게 전략적 역량이 되어가고 있습니다. 고령화, 만성 질환 유병률, 디지털 헬스 인프라 및 가치 기반 의료는 선진국과 신흥국 전반에 걸쳐 지속적인 추진력을 창출하고 있습니다.
자주 묻는 질문
목차
제1장 서문
제2장 조사 방법
제3장 주요 요약
제4장 시장 개요
제5장 시장 인사이트
제6장 AI의 누적 영향(2026년)
제7장 의료 예측 분석 시장 : 컴포넌트별
제8장 의료 예측 분석 시장 : 데이터 유형별
제9장 의료 예측 분석 시장 : 기술별
제10장 의료 예측 분석 시장 : 전개 형태별
제11장 의료 예측 분석 시장 : 조직 규모별
제12장 의료 예측 분석 시장 : 용도별
제13장 의료 예측 분석 시장 : 최종 사용자별
제14장 의료 예측 분석 시장 : 지역별
제15장 의료 예측 분석 시장 : 그룹별
제16장 의료 예측 분석 시장 : 국가별
제17장 경쟁 구도
제18장 기업 개요
AJY 26.07.27The Healthcare Predictive Analytics Market is projected to grow by USD 61.17 billion at a CAGR of 18.79% by 2032.
| KEY MARKET STATISTICS | |
|---|---|
| Base Year [2025] | USD 18.32 billion |
| Estimated Year [2026] | USD 21.60 billion |
| Forecast Year [2032] | USD 61.17 billion |
| CAGR (%) | 18.79% |
Healthcare predictive analytics is moving from retrospective reporting to real-time, evidence-driven decision support across care delivery, population health, payer operations, and life sciences. The discipline uses clinical, claims, device, pharmacy, laboratory, imaging, social determinants, and operational data to forecast risk, anticipate demand, improve quality, and reduce avoidable cost.
The market is being shaped by measurable health-system pressures. The World Health Organization reports that noncommunicable diseases account for about 74% of global deaths, while the United Nations projects the share of people aged 65 and older to rise from 10% in 2022 to 16% by 2050. These demographic and chronic-disease trends create sustained demand for predictive analytics in healthcare, including readmission risk prediction, disease progression modeling, staffing optimization, fraud detection, medication adherence, and value-based care performance management.
Transformative Shifts in Healthcare Analytics
The healthcare predictive analytics landscape is being transformed by interoperable data ecosystems, cloud-based analytics, value-based reimbursement, remote patient monitoring, and regulatory modernization. Standards such as HL7 FHIR are improving the usability of electronic health record data, while connected devices and virtual care platforms are increasing the volume of longitudinal health data available for predictive modeling.
Operationally, hospitals and payers are prioritizing analytics that can deliver measurable outcomes rather than isolated dashboards. Predictive models are increasingly embedded into clinical workflows to support earlier intervention, resource allocation, revenue cycle management, and patient engagement. At the same time, privacy, model transparency, bias mitigation, cybersecurity, and regulatory compliance have become board-level requirements as healthcare organizations scale analytics across regulated environments.
Cumulative Impact of Artificial Intelligence
Artificial intelligence is compounding the impact of healthcare predictive analytics by improving pattern recognition, natural language processing, imaging analysis, care-gap identification, and multimodal risk scoring. The U.S. Food and Drug Administration has authorized hundreds of AI-enabled medical devices, with radiology, cardiology, and neurology among the most active categories, demonstrating accelerating clinical adoption of AI-supported decision tools.
The cumulative impact is broader than automation. AI enables earlier detection of deterioration, more precise patient stratification, faster prior authorization review, and more efficient clinical documentation analysis. However, validated performance, explainability, ongoing monitoring, and governance remain essential because predictive models can degrade when clinical practices, patient populations, or coding patterns change.
Key Regional Insights
North America remains a leading region for healthcare predictive analytics due to mature electronic health record adoption, advanced payer analytics, strong cloud infrastructure, and sustained investment in value-based care. The United States is especially influential because national health expenditure represents a high share of GDP, according to CMS data, creating pressure to use predictive models for utilization management, readmission reduction, quality improvement, and fraud prevention. Canada further supports regional maturity through provincial digital health systems, population health initiatives, and public-sector emphasis on health equity.
Europe is advancing through digital health regulation, national data strategies, and the European Health Data Space, which is designed to support secure cross-border use of health data. Asia-Pacific is expanding quickly as China, India, Japan, South Korea, Australia, and ASEAN markets invest in digital hospitals, aging-care analytics, AI imaging, remote monitoring, and digital public infrastructure. Latin America is building momentum through public-sector modernization in Brazil and Mexico, where predictive analytics supports access improvement, hospital efficiency, claims integrity, and disease surveillance. The Middle East is accelerating analytics adoption through GCC health transformation programs, insurance modernization, smart hospitals, and national digital health platforms. In Africa, predictive analytics is emerging around disease surveillance, maternal health, workforce planning, vaccine logistics, and mobile-first care models, supported by rapid digital connectivity growth and public health modernization.
Key Group Insights
ASEAN presents strong long-term potential as member states expand universal health coverage, digital identity, telehealth, and hospital modernization. Predictive analytics adoption is uneven across the bloc, but demand is rising for population health management, infectious disease monitoring, claims analytics, and chronic-care optimization in high-growth markets such as Singapore, Malaysia, Thailand, Indonesia, Vietnam, and the Philippines.
The GCC is one of the most active group markets because Saudi Arabia, the United Arab Emirates, Qatar, and neighboring systems are linking health analytics to national transformation agendas, insurance modernization, and smart hospital programs. The European Union is prioritizing trusted data sharing, cybersecurity, and AI governance, creating a structured environment for scalable analytics across member states. BRICS countries offer large population datasets, expanding digital health infrastructure, and high unmet clinical needs that support predictive modeling for public health, hospital operations, and chronic disease management. G7 nations lead in research intensity, regulatory maturity, advanced clinical analytics, and AI deployment across payer and provider systems. NATO-aligned health systems add demand for resilience analytics, military medical readiness, cyber-secure data exchange, disaster response planning, and emergency preparedness.
Key Country Insights
The United States leads in payer-provider analytics, AI-enabled clinical decision support, and value-based care use cases, supported by extensive electronic health record adoption and mature reimbursement data. Canada emphasizes provincial data systems, health equity, virtual care integration, and public-sector digital health modernization. Mexico and Brazil are expanding analytics for access, claims integrity, hospital efficiency, and public health, with Brazil's large unified health system creating significant population health potential.
In Europe, the United Kingdom, Germany, France, Italy, and Spain are investing in digital health infrastructure, national health data strategies, interoperability, and AI governance, while Russia maintains demand for regional health-system optimization, medical AI applications, and hospital performance analytics. China is scaling hospital AI, imaging analytics, and public health surveillance; India is building analytics momentum through digital public infrastructure and the Ayushman Bharat Digital Mission; Japan prioritizes aging-care prediction, chronic disease management, and hospital workflow optimization; Australia is strengthening connected care, remote health analytics, and rural care delivery; and South Korea continues to advance AI diagnostics, hospital digitization, and health technology exports.
Actionable Recommendations for Industry Leaders
Industry leaders should prioritize high-value predictive analytics use cases with clear clinical, financial, or operational accountability. The strongest near-term opportunities include readmission prevention, emergency department demand forecasting, sepsis and deterioration alerts, medication adherence, risk adjustment, prior authorization optimization, fraud, waste and abuse detection, and workforce capacity planning.
Organizations should build a governance model before scaling AI. Recommended actions include improving data quality, adopting interoperable standards, validating models across demographic groups, monitoring drift, documenting model logic, strengthening cybersecurity, and aligning analytics programs with clinician workflows. Partnerships with cloud providers, academic medical centers, payers, and digital health vendors can accelerate implementation, but procurement should require evidence of safety, fairness, privacy compliance, explainability, and measurable return on investment.
Research Methodology
This executive summary is developed from a structured review of verified public sources, regulatory guidance, health-system datasets, and industry evidence relevant to healthcare predictive analytics. Core inputs include data and publications from the World Health Organization, United Nations, OECD, national health agencies, CMS, FDA, European Commission, World Bank, and peer-reviewed healthcare informatics research.
The methodology emphasizes triangulation across epidemiological trends, policy developments, technology adoption indicators, reimbursement shifts, and regional digital health initiatives. Insights are assessed for relevance to demand conditions, implementation maturity, regulatory readiness, and measurable healthcare impact. No unverified market-size estimates are used; the analysis focuses on evidence-backed drivers, risks, and strategic implications for decision-makers.
Conclusion
Healthcare predictive analytics is becoming a strategic capability for health systems, payers, governments, and life sciences organizations seeking to improve outcomes while managing cost, workforce constraints, and rising demand. Aging populations, chronic disease prevalence, digital health infrastructure, and value-based care are creating durable momentum across advanced and emerging economies.
Artificial intelligence will accelerate adoption, but sustainable value will depend on trusted data, clinical validation, interoperability, governance, and workflow integration. Organizations that combine responsible AI with measurable operational execution will be best positioned to improve patient outcomes, strengthen resilience, and compete in the next phase of data-driven healthcare.
Table of Contents
1. Preface
- 1.1. Objectives of the Study
- 1.2. Market Definition
- 1.3. Market Segmentation & Coverage
- 1.4. Years Considered for the Study
- 1.5. Currency Considered for the Study
- 1.6. Language Considered for the Study
- 1.7. Key Stakeholders
2. Research Methodology
- 2.1. Introduction
- 2.2. Research Design
- 2.2.1. Primary Research
- 2.2.2. Secondary Research
- 2.3. Research Framework
- 2.3.1. Qualitative Analysis
- 2.3.2. Quantitative Analysis
- 2.4. Market Size Estimation
- 2.4.1. Top-Down Approach
- 2.4.2. Bottom-Up Approach
- 2.5. Data Triangulation
- 2.6. Research Outcomes
- 2.7. Research Assumptions
- 2.8. Research Limitations
3. Executive Summary
- 3.1. Introduction
- 3.2. CXO Perspective
- 3.3. Market Size & Growth Trends
- 3.4. Market Share Analysis, 2025
- 3.5. FPNV Positioning Matrix, 2025
- 3.6. New Revenue Opportunities
- 3.7. Next-Generation Business Models
- 3.8. Industry Roadmap
4. Market Overview
- 4.1. Introduction
- 4.2. Industry Ecosystem & Value Chain Analysis
- 4.2.1. Supply-Side Analysis
- 4.2.2. Demand-Side Analysis
- 4.2.3. Stakeholder Analysis
- 4.3. Market Dynamics
- 4.3.1. Key Drivers
- 4.3.2. Key Restraints
- 4.3.3. Key Opportunities
- 4.3.4. Key Challenges
- 4.4. Porter's Five Forces Analysis
- 4.5. PESTLE Analysis
- 4.6. Market Outlook
- 4.6.1. Near-Term Market Outlook (0-2 Years)
- 4.6.2. Medium-Term Market Outlook (3-5 Years)
- 4.6.3. Long-Term Market Outlook (5-10 Years)
- 4.7. Go-to-Market Strategy
5. Market Insights
- 5.1. Consumer Insights & End-User Perspective
- 5.2. Consumer Experience Benchmarking
- 5.3. Opportunity Mapping
- 5.4. Distribution Channel Analysis
- 5.5. Pricing Trend Analysis
- 5.6. Regulatory Compliance & Standards Framework
- 5.7. ESG & Sustainability Analysis
- 5.8. Disruption & Risk Scenarios
- 5.9. Return on Investment & Cost-Benefit Analysis
6. Cumulative Impact of Artificial Intelligence 2026
7. Healthcare Predictive Analytics Market, by Component
- 7.1. Hardware
- 7.1.1. Data Storage Systems
- 7.1.2. Servers
- 7.1.3. Networking Devices
- 7.2. Software
- 7.3. Services
- 7.3.1. Consulting Services
- 7.3.2. Integration & Deployment Services
- 7.3.3. Support & Maintenance Services
8. Healthcare Predictive Analytics Market, by Data Type
- 8.1. Structured data
- 8.1.1. Electronic Health Records
- 8.1.2. Claims Data
- 8.1.3. Billing Data
- 8.2. Unstructured Data
- 8.2.1. Medical Imaging
- 8.2.2. Physician Reports
9. Healthcare Predictive Analytics Market, by Technology
- 9.1. Machine Learning
- 9.1.1. Supervised Learning
- 9.1.2. Unsupervised Learning
- 9.1.3. Reinforcement Learning
- 9.2. Artificial Intelligence
- 9.2.1. Deep Learning
- 9.2.2. Natural Language Processing
- 9.3. Big Data Analytics
- 9.4. Statistical Modeling
10. Healthcare Predictive Analytics Market, by Deployment
- 10.1. Cloud based
- 10.1.1. Public cloud
- 10.1.2. Private cloud
- 10.2. On-premise
11. Healthcare Predictive Analytics Market, by Organization Size
- 11.1. Large Enterprises
- 11.2. Small & Medium Enterprises
12. Healthcare Predictive Analytics Market, by Application
- 12.1. Clinical Analytics
- 12.1.1. Disease Prediction
- 12.1.2. Readmission Risk Prediction
- 12.1.3. Clinical Outcome Analysis
- 12.1.4. Diagnostic Support
- 12.1.5. Sepsis Prediction
- 12.1.6. Patient Care Enhancement
- 12.2. Financial Analytics
- 12.2.1. Revenue Cycle Management
- 12.2.2. Claims Processing Analytics
- 12.2.3. Fraud Detection
- 12.3. Administrative Analytics
- 12.4. Operational Analytics
- 12.4.1. Demand Forecasting
- 12.4.2. Inpatient Scheduling
- 12.4.3. Outpatient Scheduling
- 12.4.4. Supply Chain Analytics
- 12.5. Population Health Analytics
13. Healthcare Predictive Analytics Market, by End User
- 13.1. Healthcare Providers
- 13.1.1. Hospitals
- 13.1.2. Clinics
- 13.1.3. Ambulatory Surgical Centers
- 13.1.4. Diagnostic Centers
- 13.2. Healthcare Payers
- 13.3. Life Sciences Companies
- 13.3.1. Pharmaceutical Companies
- 13.3.2. Biotechnology Firms
- 13.3.3. Medical Device Companies
- 13.4. Academic & Research Institutes
14. Healthcare Predictive Analytics Market, by Region
- 14.1. Asia-Pacific
- 14.2. North America
- 14.3. Latin America
- 14.4. Europe
- 14.5. Middle East
- 14.6. Africa
15. Healthcare Predictive Analytics Market, by Group
- 15.1. ASEAN
- 15.2. GCC
- 15.3. European Union
- 15.4. BRICS
- 15.5. G7
- 15.6. NATO
16. Healthcare Predictive Analytics Market, by Country
- 16.1. United States
- 16.2. Canada
- 16.3. Mexico
- 16.4. Brazil
- 16.5. United Kingdom
- 16.6. Germany
- 16.7. France
- 16.8. Russia
- 16.9. Italy
- 16.10. Spain
- 16.11. China
- 16.12. India
- 16.13. Japan
- 16.14. Australia
- 16.15. South Korea
17. Competitive Landscape
- 17.1. Market Concentration Analysis, 2025
- 17.1.1. Concentration Ratio (CR)
- 17.1.2. Herfindahl Hirschman Index (HHI)
- 17.2. Recent Developments & Impact Analysis, 2025
- 17.3. Product Portfolio Analysis, 2025
- 17.4. Benchmarking Analysis, 2025
18. Company Profiles
- 18.1. Allscripts Healthcare Solutions, Inc.
- 18.2. Alteryx
- 18.3. Apixio, Inc.
- 18.4. Arcadia Solutions, LLC
- 18.5. Athenahealth, Inc.
- 18.6. Cerner Corporation
- 18.7. Cisco Systems, Inc.
- 18.8. CitiusTech Inc.
- 18.9. Clarify Health Solutions, Inc.
- 18.10. ClosedLoop.ai Inc.
- 18.11. Cloudticity, L.L.C
- 18.12. Cotiviti, Inc.
- 18.13. Epic Systems Corporation
- 18.14. GE HealthCare Technologies Inc.
- 18.15. Google LLC by Alphabet Inc.
- 18.16. Health Catalyst, Inc.
- 18.17. HealthVerity, Inc.
- 18.18. HOKUTO Inc.
- 18.19. Inovalon Holdings, Inc.
- 18.20. International Business Machines Corporation
- 18.21. IQVIA Inc.
- 18.22. Koninklijke Philips N.V.
- 18.23. McKesson Corporation
- 18.24. MedeAnalytics, Inc.
- 18.25. Microsoft Corporation
- 18.26. Optum, Inc.
- 18.27. Oracle Corporation
- 18.28. RIB Datapine GmbH
- 18.29. SAP SE
- 18.30. SAS Institute Inc.
- 18.31. Veradigm LLC
- 18.32. Verinovum
- 18.33. Virgin Pulse
- 18.34. Wipro
